<SEC-DOCUMENT>0000799698-17-000037-index.html : 20171108
<SEC-HEADER>0000799698-17-000037.hdr.sgml : 20171108
<ACCEPTANCE-DATETIME>20171107180801
ACCESSION NUMBER:		0000799698-17-000037
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171031
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171108
DATE AS OF CHANGE:		20171107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYTRX CORP
		CENTRAL INDEX KEY:			0000799698
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				581642750
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15327
		FILM NUMBER:		171184620

	BUSINESS ADDRESS:	
		STREET 1:		11726 SAN VICENTE BOULEVARD
		STREET 2:		SUITE 650
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90049
		BUSINESS PHONE:		310-826-5648

	MAIL ADDRESS:	
		STREET 1:		11726 SAN VICENTE BOULEVARD
		STREET 2:		SUITE 650
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90049
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k_11082017.htm
<DESCRIPTION>DISCLOSURE OF STRATEGIC REALIGNMENT OF DRUG DEVELOPMENT ACTIVITIES
<TEXT>
Document 1 - file: form8k_11082017.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh99_1.htm
<DESCRIPTION>PRESS RELEASE DATED NOVEMBER 6, 2017
<TEXT>
Document 2 - file: exh99_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00001.jpg
<TEXT>
Document 3 - file: image00001.jpg

</DOCUMENT>
</SEC-DOCUMENT>